Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-16-139495
Filing Date
2016-12-14
Accepted
2016-12-14 16:31:35
Documents
1
Period of Report
2016-12-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v455027_4.html 4  
1 OWNERSHIP DOCUMENT v455027_4.xml 4 8900
  Complete submission text file 0001144204-16-139495.txt   10433
Mailing Address 50 N LAURA STREET SUITE 2500 JACKSONVILLE FL 98102
Business Address 50 N LAURA STREET SUITE 2500 JACKSONVILLE FL 98102 (206) 504-7278
TAPIMMUNE INC (Issuer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MICROLIN BIO, INC. NEW YORK NY 10022
Business Address
BONFIGLIO JOHN N (Reporting) CIK: 0001222253 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37939 | Film No.: 162051433